Table-III.
Parameter | Genotypes | Osteoporosis group | Control group | ||||
---|---|---|---|---|---|---|---|
N | (M±SD) | p value | N | (M±SD) | p value | ||
Cholesterol (mg/dl) | CC | 18 | 209.2±23.1 | 0.000* | 66 | 172.1±11.2 | 0.04* |
CT | 53 | 221.8±29.21 | 56 | 179.9±13.39 | |||
TT | 67 | 248.8±26.64 | 6 | 181.33±10.01 | |||
TG (mg/dl) | CC | 18 | 109.2±25.90 | 0.05* | 66 | 82.5±9.23 | 0.24 |
CT | 53 | 120.09±32.18 | 56 | 83.83±10.38 | |||
TT | 67 | 139.07±27.80 | 6 | 93.39±14.11 | |||
HDLc (mg/dl) | CC | 18 | 44.55±3.56 | 0.000* | 66 | 44.83±3.48 | 0.05* |
CT | 53 | 47.86±3.77 | 56 | 44.48±3.25 | |||
TT | 67 | 51.06±2.69 | 6 | 48.40±2.93 | |||
LDLc (mg/dl) | CC | 18 | 142.7±19.11 | 0.000* | 66 | 107.2±12.16 | 0.17 |
CT | 53 | 147.52±29.29 | 56 | 117.6±13.27 | |||
TT | 67 | 169.14±22.21 | 6 | 119.33±11.75 | |||
Z score | CC | 18 | -2.10±0.42 | 0.01* | 66 | 1.27±0.93 | 0.03* |
CT | 53 | -2.37±0.48 | 56 | 1.26±1.07 | |||
TT | 67 | -2.80±0.25 | 6 | 1.02±1.04 | |||
T score | CC | 18 | -2.16±0.44 | 0.02* | 66 | 1.23±0.91 | 0.05* |
CT | 53 | -2.38±0.49 | 56 | 1.25±1.04 | |||
TT | 67 | -2.72±0.26 | 6 | 0.98±1.07 | |||
Serum Amyloid A (ug/ml) | CC | 18 | 9.22±2.31 | 0.000* | 66 | 2.01±1.70 | 0.05* |
CT | 53 | 14.79±3.62 | 56 | 3.50±1.83 | |||
TT | 67 | 19.09±3.69 | 6 | 6.00±1.41 |